259 related articles for article (PubMed ID: 15102601)
1. Use of suicide genes for cancer gene therapy: study of the different approaches.
Vassaux G; Martin-Duque P
Expert Opin Biol Ther; 2004 Apr; 4(4):519-30. PubMed ID: 15102601
[TBL] [Abstract][Full Text] [Related]
2. The emerging fields of suicide gene therapy and virotherapy.
Kirn D; Niculescu-Duvaz I; Hallden G; Springer CJ
Trends Mol Med; 2002; 8(4 Suppl):S68-73. PubMed ID: 11927291
[TBL] [Abstract][Full Text] [Related]
3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
[TBL] [Abstract][Full Text] [Related]
5. Origins of Suicide Gene Therapy.
Düzgüneş N
Methods Mol Biol; 2019; 1895():1-9. PubMed ID: 30539525
[TBL] [Abstract][Full Text] [Related]
6. The role of the bystander effect in suicide gene therapy.
Pope IM; Poston GJ; Kinsella AR
Eur J Cancer; 1997 Jun; 33(7):1005-16. PubMed ID: 9376180
[No Abstract] [Full Text] [Related]
7. Gene therapy in human cancer: report of human clinical trials.
Wasil T; Buchbinder A
Cancer Invest; 2000; 18(8):740-6. PubMed ID: 11107444
[No Abstract] [Full Text] [Related]
8. Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer.
Hsiao WC; Sung SY; Chung LWK; Hsieh CL
Methods Mol Biol; 2019; 1895():27-42. PubMed ID: 30539527
[TBL] [Abstract][Full Text] [Related]
9. Design of prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Springer CJ
Methods Mol Med; 2004; 90():161-202. PubMed ID: 14657564
[No Abstract] [Full Text] [Related]
10. Suicide gene therapy in cancer: where do we stand now?
Duarte S; Carle G; Faneca H; de Lima MC; Pierrefite-Carle V
Cancer Lett; 2012 Nov; 324(2):160-70. PubMed ID: 22634584
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
13. Immune response to suicide gene therapy.
Kuriyama S; Tsujinoue H; Yoshiji H
Methods Mol Med; 2004; 90():353-69. PubMed ID: 14657573
[No Abstract] [Full Text] [Related]
14. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells.
Hossain JA; Ystaas LR; Mrdalj J; Välk K; Riecken K; Fehse B; Bjerkvig R; Grønli J; Miletic H
J Gene Med; 2016 Sep; 18(9):234-43. PubMed ID: 27490042
[TBL] [Abstract][Full Text] [Related]
16. Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots.
Shao D; Zeng Q; Fan Z; Li J; Zhang M; Zhang Y; Li O; Chen L; Kong X; Zhang H
Biomaterials; 2012 Jun; 33(17):4336-44. PubMed ID: 22440046
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy for hepatocellular carcinoma].
Ohashi M; Kanai F; Shiratori Y; Omata M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():699-704. PubMed ID: 11762040
[No Abstract] [Full Text] [Related]
18. Advances in imaging gene-directed enzyme prodrug therapy.
Bhaumik S
Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumors.
Culver KW; Moorman DW; Muldoon RR; Paulsen RM; Lamsam JL; Walling HW; Link CJ
Cold Spring Harb Symp Quant Biol; 1994; 59():685-90. PubMed ID: 7587131
[No Abstract] [Full Text] [Related]
20. Inhibition of prostate cancer by suicide gene targeting the FCY1 and HSV-TK genes.
Yue QH; Hu XB; Yin Y; Su MQ; Cheng XD; Yang L; Zhou TC; Hao X
Oncol Rep; 2009 Dec; 22(6):1341-7. PubMed ID: 19885585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
